Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03566160 · ClinicalTrials.gov registry record · NA
Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy
A NA study of Gastrointestinal Disease, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03566160 is a NA study of Gastrointestinal Disease that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 30 participants, below the 2,412-participant average among 7 other Gastrointestinal Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03566160, a NA study of Gastrointestinal Disease, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Environmental enteric dysfunction (EED) is a poorly understood condition characterized by intestinal inflammation and loss of barrier function that is prevalent in regions of the world with inadequate sanitation and hygiene. EED is a major driver of malnourishment, poor neurological development, stunting, oral vaccine failure, and infection, affecting 25% of all children globally and causing over a million deaths each year. Progress towards understanding EED and developing effective interventions has been hampered by an inability to evaluate the intestinal mucosa of populations in impoverished regions of the world where this condition is endemic. In order to prevent the deleterious and permanent sequelae of the disease, there is a need for effective diagnosis and intervention to be implemented in EED patients before the age of 2. Currently, the only means for directly evaluating the intestine is endoscopy with mucosal biopsy. Unfortunately, endoscopy is untenable for the study of EED because of limited resources and the high cost. As a result, there is a clear, unmet need for a less invasive tool that can be used in low-and-middle-income-countries (LMICs) to evaluate the intestine in population with EED. This work is supported by a grant from The Bill and Melinda Gates Foundation (BMGF). The overall goal is to provide a minimally invasive means of obtaining detailed infantile intestinal tissue information that is needed for the development of effective EED interventions. Obtaining biopsies will play a critical role in gathering the detailed intestinal tissue information. The purpose of this study is to explore the feasibility of utilizing a cryobiopsy probe to obtain biopsies in adults.
Conditions Studied
Interventions
- DEVICE Cryobiopsy probe, administered to study participants
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-09-05 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03566160
The ClinicalTrials.gov registry entry for NCT03566160 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,412-participant average among 7 other Gastrointestinal Disease trials with a reported enrollment target (99% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastrointestinal Disease appearing as the primary indexed condition, and to 1 intervention - of which Cryobiopsy probe, administered to study participants is the first listed.
NCT03566160 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03566160 about?
NCT03566160 is a clinical study titled "Pilot Study for Evaluation of Cryobiopsy and Correlation With Standard Forceps Biopsy". Environmental enteric dysfunction (EED) is a poorly understood condition characterized by intestinal inflammation and loss of barrier function that is prevalent in regions of the world with inadequate sanitation and hygiene. EED is a major driver of malnourishment, poor neurological development, stu...
What is the current status of trial NCT03566160?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2018-09-05. Estimated completion is 2027-12-30.
What conditions does trial NCT03566160 study?
This clinical trial studies the following conditions: Gastrointestinal Disease.
What interventions are being tested in trial NCT03566160?
The interventions under investigation include: Cryobiopsy probe, administered to study participants (DEVICE).
Who is sponsoring clinical trial NCT03566160?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03566160 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advancing Nursing Practices in Hospital Oncology Care
ACTIVE NOT RECRUITING · NA
-
Optimizing Gastrointestinal Procedure Appointments
COMPLETED · NA
-
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
COMPLETED · NA
-
FDG-PET-CT and Biomarkers in Esophageal Cancer
COMPLETED · NA
-
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)
COMPLETED · Phase 4
-
A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.